Can-Fite BioPharma Ltd. ROE Ratio 2011-2026 | CANF

Annual ROE Ratio Can-Fite BioPharma Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-175.75	-144.96	-122.28	-227.48	-87.71	-237.78	-516.99	-217.94	163.5	181.31	48.5	357.66	-187.11	787.15	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
787.15	-516.99	-27.14

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	1.11	$ 97.54	-5.71 %	$ 27.2 B	Germany
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Burford Capital Limited BUR	10.1	$ 5.2	5.69 %	$ 820 M	Britain
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Cerus Corporation CERS	-24.33	$ 2.72	33.99 %	$ 518 M	USA
ACADIA Pharmaceuticals ACAD	30.9	$ 21.95	-2.23 %	$ 3.64 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-380.03	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
Atreca BCEL	-123.92	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	-69.02	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	-1373.04	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	-36.05	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	-46.05	-	-	$ 3.74 B	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Cardiff Oncology CRDF	-101.02	$ 1.71	-1.16 %	$ 114 M	USA
Caladrius Biosciences CLBS	-67.58	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	-88.4	-	-	$ 231 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	103.22	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	-55.55	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Editas Medicine EDIT	-586.56	$ 2.9	-3.33 %	$ 257 M	USA
Dynavax Technologies Corporation DVAX	4.58	-	-	$ 2.02 B	USA
Edesa Biotech EDSA	-311.44	$ 17.59	-3.75 %	$ 56.2 M	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
Eiger BioPharmaceuticals EIGR	518.49	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	338.32	-	-5.68 %	$ 8.28 M	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Evogene Ltd. EVGN	-41.09	$ 0.81	3.33 %	$ 27.9 M	Israel
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	125.33	-	17.91 %	$ 11.1 M	USA